JPS596854B2 - Bromination method for heterocycle-containing heterocyclic compounds - Google Patents
Bromination method for heterocycle-containing heterocyclic compoundsInfo
- Publication number
- JPS596854B2 JPS596854B2 JP48131177A JP13117773A JPS596854B2 JP S596854 B2 JPS596854 B2 JP S596854B2 JP 48131177 A JP48131177 A JP 48131177A JP 13117773 A JP13117773 A JP 13117773A JP S596854 B2 JPS596854 B2 JP S596854B2
- Authority
- JP
- Japan
- Prior art keywords
- bromine
- containing heterocyclic
- mixture
- heterocyclic compound
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000005893 bromination reaction Methods 0.000 title claims description 13
- 150000002391 heterocyclic compounds Chemical class 0.000 title claims description 7
- 238000000034 method Methods 0.000 title description 18
- 230000031709 bromination Effects 0.000 title description 7
- 125000000623 heterocyclic group Chemical group 0.000 title description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 34
- 229910052794 bromium Inorganic materials 0.000 claims description 34
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 33
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 26
- 239000002904 solvent Substances 0.000 claims description 23
- 239000011541 reaction mixture Substances 0.000 claims description 15
- GYCPLYCTMDTEPU-UHFFFAOYSA-N 5-bromopyrimidine Chemical compound BrC1=CN=CN=C1 GYCPLYCTMDTEPU-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 9
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 claims description 8
- SDPYFZLDWYNXJF-UHFFFAOYSA-N 5-bromo-4-phenylpyrimidine Chemical compound BrC1=CN=CN=C1C1=CC=CC=C1 SDPYFZLDWYNXJF-UHFFFAOYSA-N 0.000 claims description 7
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 6
- MKLQPIYLZMLAER-UHFFFAOYSA-N 4-phenylpyrimidine Chemical compound C1=CC=CC=C1C1=CC=NC=N1 MKLQPIYLZMLAER-UHFFFAOYSA-N 0.000 claims description 5
- ZGIKWINFUGEQEO-UHFFFAOYSA-N 3-bromoquinoline Chemical compound C1=CC=CC2=CC(Br)=CN=C21 ZGIKWINFUGEQEO-UHFFFAOYSA-N 0.000 claims description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 4
- VSOSXKMEQPYESP-UHFFFAOYSA-N 1,6-naphthyridine Chemical compound C1=CN=CC2=CC=CN=C21 VSOSXKMEQPYESP-UHFFFAOYSA-N 0.000 claims description 3
- CFBYEGUGFPZCNF-UHFFFAOYSA-N 2-nitroanisole Chemical compound COC1=CC=CC=C1[N+]([O-])=O CFBYEGUGFPZCNF-UHFFFAOYSA-N 0.000 claims description 3
- PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical compound CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 claims description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 3
- 239000011874 heated mixture Substances 0.000 claims description 3
- XGNQDLUHEFXGPL-UHFFFAOYSA-N 3,8-dibromo-1,6-naphthyridine Chemical compound BrC1=CN=CC2=CC(Br)=CN=C21 XGNQDLUHEFXGPL-UHFFFAOYSA-N 0.000 claims description 2
- YWWZASFPWWPUBN-UHFFFAOYSA-N 1-bromoisoquinoline Chemical compound C1=CC=C2C(Br)=NC=CC2=C1 YWWZASFPWWPUBN-UHFFFAOYSA-N 0.000 claims 1
- 150000004767 nitrides Chemical class 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 39
- -1 nitrogen-containing heterocyclic compounds Chemical class 0.000 description 29
- 239000000203 mixture Substances 0.000 description 26
- 239000007787 solid Substances 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 229910000039 hydrogen halide Inorganic materials 0.000 description 8
- 239000012433 hydrogen halide Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000002002 slurry Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- SCRBSGZBTHKAHU-UHFFFAOYSA-N 4-bromoisoquinoline Chemical compound C1=CC=C2C(Br)=CN=CC2=C1 SCRBSGZBTHKAHU-UHFFFAOYSA-N 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000012259 ether extract Substances 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003822 preparative gas chromatography Methods 0.000 description 4
- IDXKTTNFXPPXJY-UHFFFAOYSA-N pyrimidin-1-ium;chloride Chemical compound Cl.C1=CN=CN=C1 IDXKTTNFXPPXJY-UHFFFAOYSA-N 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002026 chloroform extract Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000013076 target substance Substances 0.000 description 3
- KVJHGPAAOUGYJX-UHFFFAOYSA-N 1,1,3,3-tetraethoxypropane Chemical compound CCOC(OCC)CC(OCC)OCC KVJHGPAAOUGYJX-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- PSXRWZBTVAZNSF-UHFFFAOYSA-N hydron;quinoline;chloride Chemical compound Cl.N1=CC=CC2=CC=CC=C21 PSXRWZBTVAZNSF-UHFFFAOYSA-N 0.000 description 2
- IYRMNDOLPONSCJ-UHFFFAOYSA-N isoquinolin-2-ium;chloride Chemical compound Cl.C1=NC=CC2=CC=CC=C21 IYRMNDOLPONSCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000005648 plant growth regulator Substances 0.000 description 2
- BATMYWDOUUWCJE-UHFFFAOYSA-N pyrimidin-1-ium;bromide Chemical compound Br.C1=CN=CN=C1 BATMYWDOUUWCJE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- BOOFDWVIWBJODW-UHFFFAOYSA-N 1,8-naphthyridine;hydrochloride Chemical compound Cl.N1=CC=CC2=CC=CN=C21 BOOFDWVIWBJODW-UHFFFAOYSA-N 0.000 description 1
- QGRPVMLBTFGQDQ-UHFFFAOYSA-N 1-chloro-2-methoxybenzene Chemical compound COC1=CC=CC=C1Cl QGRPVMLBTFGQDQ-UHFFFAOYSA-N 0.000 description 1
- LNGFSVBKDJEZTF-UHFFFAOYSA-N 2-bromo-1,1,3,3-tetraethoxypropane Chemical compound CCOC(OCC)C(Br)C(OCC)OCC LNGFSVBKDJEZTF-UHFFFAOYSA-N 0.000 description 1
- OXPDQFOKSZYEMJ-UHFFFAOYSA-N 2-phenylpyrimidine Chemical compound C1=CC=CC=C1C1=NC=CC=N1 OXPDQFOKSZYEMJ-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- IEJBHGRSGHMNTB-UHFFFAOYSA-N 4-phenylpyrimidine hydrobromide Chemical compound Br.C1(=CC=CC=C1)C1=NC=NC=C1 IEJBHGRSGHMNTB-UHFFFAOYSA-N 0.000 description 1
- DCHUYAXTJQCCRX-UHFFFAOYSA-N 4-phenylpyrimidine;hydrochloride Chemical compound Cl.C1=CC=CC=C1C1=CC=NC=N1 DCHUYAXTJQCCRX-UHFFFAOYSA-N 0.000 description 1
- WGDHEJVNOWBUCH-UHFFFAOYSA-N 5-bromopyrimidine;hydrobromide Chemical compound Br.BrC1=CN=CN=C1 WGDHEJVNOWBUCH-UHFFFAOYSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- GDKWFLJNGDCPDY-UHFFFAOYSA-N [Br-].c1cnc2cc[nH+]cc2c1 Chemical compound [Br-].c1cnc2cc[nH+]cc2c1 GDKWFLJNGDCPDY-UHFFFAOYSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910001867 inorganic solvent Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- SHLPPXXKRFINFY-UHFFFAOYSA-N isoquinolin-2-ium;bromide Chemical compound Br.C1=NC=CC2=CC=CC=C21 SHLPPXXKRFINFY-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- KCDACWMWSAEJNW-UHFFFAOYSA-N methanol;pyrimidine Chemical class OC.C1=CN=CN=C1 KCDACWMWSAEJNW-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- YHQSXWOXIHDVHQ-UHFFFAOYSA-N quinoline;hydrobromide Chemical compound [Br-].[NH+]1=CC=CC2=CC=CC=C21 YHQSXWOXIHDVHQ-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B39/00—Halogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
この発明は窒素含有異項環化合物のβ=ブロム化法に関
する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a process for β=bromination of nitrogen-containing heterocyclic compounds.
本発明によれば、ブロム化反応の条件下でブロムの作用
に対して実質的に不活性の溶媒中、窒素含有異項環化合
物にその・・ロゲン化水素酸付加塩の形で高温でブロム
を反応させることによつて上記窒素含有異項環化合物を
β−ブロム化(異項環化合物の窒素原子のβ位の炭素原
子をブロム化すること)することができる。この発明に
よる生成物、例えば5−ブロムピリミジンはいくつかの
新しい農業用薬剤、殊に興味ある植物生長調整剤および
植物殺菌剤合成の中間体として有効であることが立証さ
れている。これらの薬剤が重要な物質であることから、
本発明者はその重要な中間体である5−ブロムピリミジ
ンのより簡単な合成方法の研究に着手するに至つた。従
来、ブレデレツク(Bredereck)等は次の方法
を教示している〔ヘミツシエ・ベリヒテ第91巻384
8頁における2832(1958年)参照〕。According to the present invention, a nitrogen-containing heterocyclic compound is subjected to bromination at elevated temperature in the form of its hydrologonic acid addition salt in a solvent substantially inert to the action of bromine under the conditions of the bromination reaction. The above nitrogen-containing heterocyclic compound can be subjected to β-bromination (bromination of the carbon atom at the β-position of the nitrogen atom of the heterocyclic compound) by reacting with . The products according to the invention, such as 5-brompyrimidine, have proven useful as intermediates in the synthesis of several new agricultural drugs, particularly interesting plant growth regulators and plant fungicides. Since these drugs are important substances,
The present inventor has begun research on a simpler method for synthesizing 5-brompyrimidine, which is an important intermediate thereof. Previously, Bredereck et al. taught the following method [Hemitsier Berichte Vol. 91, 384]
2832 (1958) on page 8].
即ち、ピリミジン・塩酸塩とブロムの混合物を油浴上で
約3時間、約160℃に加熱して固形の反応生成物を生
じさせ、油浴の温度を更に250℃に上昇させて5−ブ
ロムピリミジン・臭化水素酸塩を減圧下で固体反応混合
物から昇華させる。この5−ブロムピリミジン・臭化水
素酸塩を亜硫酸ナトリウム溶液に吸収し、これを水酸化
カリウムでアルカリ性にし、クロロホルムで抽出する。
クロロホルムを留去することにより純粋な5−ブロムピ
リミジンを製造する方法が示される。5−ブロムピリミ
ジン合成の他の方法もブレデレツク等によつて報告され
ている〔ヘミツシエ・ベリヒテ第95巻807〜808
頁における803(1962年)参照〕。That is, a mixture of pyrimidine hydrochloride and bromine is heated to about 160°C on an oil bath for about 3 hours to form a solid reaction product, and the temperature of the oil bath is further increased to 250°C to produce 5-bromine. The pyrimidine hydrobromide salt is sublimed from the solid reaction mixture under reduced pressure. The 5-bromopyrimidine hydrobromide is taken up in sodium sulfite solution, made alkaline with potassium hydroxide and extracted with chloroform.
A method for producing pure 5-bromopyrimidine by distilling off chloroform is presented. Other methods for the synthesis of 5-bromopyrimidine have also been reported by Bredereck et al.
803 (1962)].
即ち、2−ブロム−1・1・3・3−テトラエトキシプ
ロパンは1・1・3・3−テトラエトキシプロパンを四
塩化炭素中でブロム化することによつて得られる。また
、ギ酸アンモニウムおよび水の存在下で2−ブロム1・
1・3・3−テトラエトキシプロパンとホルムアミドを
縮合することにより5−ブロムピリミジンが得られるこ
とが報告されている。4−ブロムイソキノリンの製法は
ギルマン(Gilman)等によつて報告されている〔
ザ・ジヤーナル・オブ・ジ・アメリカン・ケミカル・ソ
サエテイ第69巻1946頁(1947年)〕。That is, 2-bromo-1,1,3,3-tetraethoxypropane can be obtained by brominating 1,1,3,3-tetraethoxypropane in carbon tetrachloride. In addition, 2-bromo 1.
It has been reported that 5-bromopyrimidine can be obtained by condensing 1,3,3-tetraethoxypropane and formamide. A method for producing 4-bromoisoquinoline has been reported by Gilman et al.
The Journal of the American Chemical Society, Vol. 69, p. 1946 (1947)].
イソキノリンパープロミド・臭化水素酸塩を長く加熱す
ると固体が得られる。これに過剰の水酸化ナトリウム水
溶液を加え、遊離した4−ブロムイソキノリンを水蒸気
蒸溜によつて回収する。この粗生成物を石油エーテルか
ら再結晶して精製している。5−ブロム−4−フエニル
ピリミジンを6工程の合成過程で製造する方法がフアン
・デル・プラス(VanderPlas)によつて報告
されている〔ルクイユ・デ・トラボ・シユミク・デ・ペ
イユ・バ第84巻1101頁(1965年)参照]。Prolonged heating of isoquinoline perpromide hydrobromide produces a solid. Excess sodium hydroxide aqueous solution is added to this, and the liberated 4-bromoisoquinoline is recovered by steam distillation. This crude product is purified by recrystallization from petroleum ether. A method for producing 5-bromo-4-phenylpyrimidine in a six-step synthetic process has been reported by VanderPlas 84, p. 1101 (1965)].
彼は上記ブレデレツク等の直接プロム化法は5−ブロム
−4−フエニルピリミジンの合成には、フエニル基がブ
ロム化剤で攻撃され易いので適当でないと述べている。
キノリンパ−フロミド・臭化水素酸塩を180〜200
゜Cで熱分解して3−プロムキノリンを得る製造法がア
イシユによつて報告されている〔ザ・ジヤーナル・オブ
・オーガニツク・ケミストリ一第27巻1318頁(1
962年)参照〕。He states that the direct bromination method of Bredereck et al. is not suitable for the synthesis of 5-bromo-4-phenylpyrimidine because the phenyl group is easily attacked by the bromination agent.
Quinolymph furomide/hydrobromide 180-200
A production method for obtaining 3-promquinoline by thermal decomposition at °C has been reported by Ishiyu [The Journal of Organic Chemistry Vol. 1, Vol. 27, p. 1318 (1).
962)].
本発明は窒素含有異項環化合物のβ−ブロム化に関する
ものであつて、本発明によれば特に、ピリミジン、4−
フエニルピリミジン、キノリン、イソキノリンおよび1
・6−ナフチリジンから選ばれた窒素含有異項環化合物
をβ−ブロム化することができる。本発明の方法は、反
応の条件下でブロムの作用に対して実質的に不活性な溶
媒と窒素含有異項環化合物の・・ロゲン化水素酸塩の加
熱混合物に、一定時間に渡り一定速度でブロムを添加す
ることより成るものである。本発明は、β−ブロム置換
窒素含有異項環化合物、例えば5−ブロムピリミジンを
好収率で得る方法を提供するもので、商業的に採用でき
る方法である。The present invention relates to β-bromination of nitrogen-containing heterocyclic compounds, and in particular, pyrimidine, 4-bromination,
phenylpyrimidine, quinoline, isoquinoline and 1
- A nitrogen-containing heterocyclic compound selected from 6-naphthyridine can be β-brominated. The process of the present invention involves adding a heated mixture of a solvent substantially inert to the action of bromine under the reaction conditions and a hydrologenide salt of a nitrogen-containing heterocyclic compound at a constant rate over a period of time. It consists of adding bromine. The present invention provides a method for obtaining a β-bromo-substituted nitrogen-containing heterocyclic compound, such as 5-bromopyrimidine, in good yield, and is a commercially applicable method.
この方法は窒素含有異項環化合物に一般に適用できるこ
とが見出された。β−ブロム置換窒素含有異項環化合物
の製造は窒素含有異項環化合物のハロゲン化水素酸付加
塩を使用して有利に実施される。It has been found that this method is generally applicable to nitrogen-containing heterocyclic compounds. The production of the β-bromo-substituted nitrogen-containing heterocyclic compound is advantageously carried out using a hydrohalic acid addition salt of the nitrogen-containing heterocyclic compound.
適当なハロゲン化水素酸付加塩としては塩酸塩、臭化水
素酸塩、ヨ一化水素酸塩、例えばピリミジン・塩酸塩、
ピリミジン臭化水素酸塩、ピリミジン・ヨ一化水素酸塩
、キノリン・塩酸塩、キノリン・臭化水素酸塩、キノリ
ン・ヨ一化水素酸塩、イソキノリン・臭化水素酸塩、イ
ソキノリン・塩酸塩、イソキノリン・ヨ一化水素酸塩、
4−フエニルピリミジン・臭化水素酸塩、4−フエニル
ピリミジン・塩酸塩、4一フエニルピリミジン・ヨ一化
水素酸塩、1・6ナフチリジン・臭化水素酸塩、1・6
−ナフチリジン・塩酸塩、1・6−ナフチリジン・ヨ一
化水素酸塩が含まれる。これらのハロゲン化水素酸塩の
内、塩酸塩がこの発明のブロム化の使用に好適である。
窒素含有異項環化合物・ハロゲン化水素酸塩は適当な反
応溶媒に懸濁、または溶解し、加熱し、これにブロムを
添加する。Suitable hydrohalic acid addition salts include hydrochloride, hydrobromide, hydroiomonide, such as pyrimidine hydrochloride,
Pyrimidine hydrobromide, pyrimidine hydroiomonide, quinoline hydrochloride, quinoline hydrobromide, quinoline hydroiomonide, isoquinoline hydrobromide, isoquinoline hydrochloride , isoquinoline hydroiomonide,
4-phenylpyrimidine hydrobromide, 4-phenylpyrimidine hydrochloride, 4-phenylpyrimidine hydroiomonide, 1,6 naphthyridine hydrobromide, 1,6
-Includes naphthyridine hydrochloride and 1,6-naphthyridine hydroiomonide. Of these hydrohalides, the hydrochloride salt is preferred for use in the bromination of this invention.
The nitrogen-containing heterocyclic compound/hydrohalide is suspended or dissolved in a suitable reaction solvent, heated, and bromine is added thereto.
ブロムと窒素含有異項環化合物・ハロゲン化水素酸塩は
、最初に錯体を形成し、この錯体が反応溶媒に溶解する
。溶媒はこの反応の条件下で、ブロムに対して実質的に
不活性であるものを選択する。好ましい溶媒は出発物質
である窒素含有異項環化合物・ハロゲン化水素酸塩を溶
解せず、ブロムと窒素含有異項環化合物・・・ロゲン化
水素酸塩の錯体を完全に溶解し、そして目的物であるブ
ロム置換窒素含有異項環化合物・・・ロゲン化水素酸塩
を実質的に溶解しない溶媒である。かかる好ましい溶媒
としては塩化チオニルおよびオキシ塩化リンなどの無機
溶媒および四塩化炭素、ニトロベンゼン、オルトジクロ
ロベンゼン、クロロベンゼン、オルトニトロトルエン、
ベンゾニトリル、オルトニトロアニソール、オルトクロ
ロアニソール等の有機溶媒が挙げられる。これらのすべ
ての溶媒は、本発明の新規方法の条件下で実質的にブロ
ムに対して不活性である。上記の溶媒は何れも目的物質
であるブロム置換窒素含有異項環化合物を好収率で得る
のに有用であるが、就中、取扱いの容易性と再使用の可
能性の理由から有機溶媒がより望ましい。有機溶媒であ
るベンゾニトリル、o−ニトロトルエン、o−ジクロロ
ベンゼン、o−ニトロアニソールおよびニトロベンゼン
は好収率で得るため特に有用である。これらの有機溶媒
の内、o−ジクロロベンゼンおよびニトロベンゼンが好
ましく、この内特にニトロベンゼンが好ましい。溶媒は
、この発明の重要な部分を占める。Bromine and the nitrogen-containing heterocyclic compound/hydrohalide first form a complex, and this complex is dissolved in the reaction solvent. The solvent is chosen to be substantially inert towards bromine under the conditions of this reaction. A preferred solvent does not dissolve the starting material, the nitrogen-containing heterocyclic compound/hydrohalide, but completely dissolves the complex of bromine and the nitrogen-containing heterocyclic compound/hydrohalide, and A bromine-substituted nitrogen-containing heterocyclic compound, which is a substance, is a solvent that does not substantially dissolve the hydrologenide salt. Such preferred solvents include inorganic solvents such as thionyl chloride and phosphorus oxychloride, and carbon tetrachloride, nitrobenzene, orthodichlorobenzene, chlorobenzene, orthonitrotoluene,
Examples include organic solvents such as benzonitrile, orthonitroanisole, orthochloroanisole. All these solvents are substantially inert towards bromine under the conditions of the new process of the invention. All of the above-mentioned solvents are useful for obtaining the target substance, a bromine-substituted nitrogen-containing heterocyclic compound, in a good yield, but organic solvents are especially useful for ease of handling and possibility of reuse. More desirable. The organic solvents benzonitrile, o-nitrotoluene, o-dichlorobenzene, o-nitroanisole and nitrobenzene are particularly useful since they can be obtained in good yields. Among these organic solvents, o-dichlorobenzene and nitrobenzene are preferred, and nitrobenzene is particularly preferred. Solvents are an important part of this invention.
溶媒は反応混合物の温度の調整を補助し、ブロムと窒素
含有異項環化合物・ハロゲン化水素酸塩とのよりよき混
合を可能にする。溶媒は反応の間を通じて反応混合物の
攪拌を可能にする。また溶媒のないときよりも生成物を
高収率で得ることを可能にする。反応が進行するにつれ
て反応生成物混合物が固形物となる先行技術とは対照的
に、本発明方法の反応生成物混合物は攪拌することがで
きる。溶媒の存在は、更にβ−ブロム置換窒素含有異項
環化合物の分離を容易にする。不活性溶媒の存在下では
反応容器中で反応混合物は反応完結時に固体ではなくス
ラリーとして存在しており、粗製の目的物は溶媒から劇
1することができる。このことは、反応容器から製品を
昇華またはかきとつて分離することに比較して、特に大
量生産の場合に有利である。このように不活性溶媒の存
在は大量生産を実施する上に大きな助けとなる。ブロム
化反応は、例えばニトロベンゼンの如き不活性溶媒中で
窒素含有異項環化合物のハロゲン化水素酸付加塩を懸濁
させ、この混合物を適当な温度に加熱することによつて
行われる。The solvent helps regulate the temperature of the reaction mixture and allows better mixing of the bromine and the nitrogen-containing heterocyclic compound/hydrohalide. The solvent allows stirring of the reaction mixture throughout the reaction. It also makes it possible to obtain a higher yield of product than without the solvent. In contrast to the prior art, where the reaction product mixture becomes solid as the reaction progresses, the reaction product mixture of the process of the invention can be stirred. The presence of a solvent further facilitates the separation of the β-bromo substituted nitrogen-containing heterocyclic compound. In the presence of an inert solvent, the reaction mixture exists in the reaction vessel as a slurry rather than a solid upon completion of the reaction, and the crude target product can be removed from the solvent. This is advantageous, especially in the case of mass production, compared to separating the product from the reaction vessel by sublimation or scraping. The presence of an inert solvent thus greatly aids in carrying out mass production. The bromination reaction is carried out, for example, by suspending the hydrohalic acid addition salt of the nitrogen-containing heterocyclic compound in an inert solvent such as nitrobenzene, and heating the mixture to an appropriate temperature.
適当な温度は異項環反応物によつて異なり、約125゜
C(ピリミジンの場合)から約200℃(キノリンの場
合)までである。ブロムは加熱した混合物に約30〜約
90分を要して添加する。Suitable temperatures vary depending on the heterocyclic reactant and range from about 125°C (for pyrimidines) to about 200°C (for quinolines). The bromine is added to the heated mixture over a period of about 30 to about 90 minutes.
この添加はブロムと窒素含有異項環化合物の反応が支障
なく制御されるような速度で実施するのが好ましい。実
験室では30分ないし90分に渡るブロムの添加は滴下
によるのが望ましい。ブロムの添加は不均等間隔で不均
等に添加しても反応は完結するであろうが、均等量を均
等時間間隔で加えて反応を完結させるのが望ましい。ブ
ロムを添加すると、・・ロゲン化水素が反応混合物から
発生する。This addition is preferably carried out at a rate such that the reaction between the bromine and the nitrogen-containing heterocyclic compound is well controlled. In the laboratory, it is preferred to add the bromine dropwise over a period of 30 to 90 minutes. Although the reaction may be completed even if bromine is added unevenly at unequal intervals, it is preferable to complete the reaction by adding equal amounts at equal time intervals. Upon addition of bromine... hydrogen halogenide is evolved from the reaction mixture.
ハロゲン化水素の発生の速度はブロムの添加速度によつ
て規制される。ハロゲン化水素の発生速度の調製は重要
なことである。余りにハロゲン化水素の急激な発生は添
加したブロムを随伴するおそれがある。この随伴はブロ
ムの損失を招き、生成物の収率を低下させ、生産費を上
昇させることになる。ハロゲン化水素発生速度の制御は
、また反応から生ずるガスをハロゲン化水素を除去する
ためにガス洗浄器に通すのが望ましいという点からみて
も重要である。かXる除去はできるだけ大気を汚さない
様にするための措置として望ましい。かくの如く、反応
が実験室規模であろうと、商業的規模であろうと、ブロ
ムの添加はハロゲン化水素への随伴やブロムの損失を予
防し反応によつて生ずるガスからハロゲン化水素を充分
に除去できるようにハロゲン化水素の発生速度を制御で
きる速度で実行されるのが望ましい。ブロムの添加終了
後、反応混合物は反応を完結させるために更にある時間
、約2〜6時間加熱する。これによつて、中間生成物た
る窒素含有異項環化合物のハロゲン化水素酸塩とブロム
との錯体が熱分解し、所望のβ−ブロム化合物のハロゲ
ン化水素酸塩が形成する。余り長い時間加熱すると目的
物の収率が低下するのでそれはさけるべきである。加熱
時間はブロム化される異項環化合物にも依る。加熱を終
つた時点で反応生成混合物を常套の方法による最終段階
の工程に投入する。The rate of hydrogen halide generation is regulated by the rate of bromine addition. Controlling the generation rate of hydrogen halide is important. If hydrogen halide is generated too rapidly, there is a risk that the added bromine will be accompanied. This entrainment results in loss of bromine, lowering product yield and increasing production costs. Control of the hydrogen halide generation rate is also important in that it is desirable to pass the gas resulting from the reaction through a gas scrubber to remove the hydrogen halide. Such removal is desirable as a measure to avoid polluting the atmosphere as much as possible. Thus, whether the reaction is carried out on a laboratory scale or on a commercial scale, the addition of bromine prevents entrainment and loss of bromine to the hydrogen halide and ensures that sufficient hydrogen halide is removed from the gas produced by the reaction. It is desirable to carry out the process at a rate that allows the rate of generation of hydrogen halide to be controlled so that it can be removed. After the bromine addition is complete, the reaction mixture is heated for an additional period of time, about 2 to 6 hours, to complete the reaction. As a result, the complex of the intermediate hydrohalide of the nitrogen-containing heterocyclic compound and bromine is thermally decomposed, and the desired hydrohalide of the β-brome compound is formed. Heating for too long will reduce the yield of the target product and should be avoided. The heating time also depends on the heterocyclic compound to be brominated. At the end of heating, the reaction product mixture is fed to the final step in a conventional manner.
即ち、反応生成混合物をある程度冷却し、溶媒、例えば
ベンゼンを加える。他の溶媒としてヘキサン、エーテル
、トルエンおよびキシレンなども使用できる。加えた溶
媒は不活性溶媒を希釈し、目的物質を不活性溶媒から分
離するのに役立つ。希釈溶媒を添加した後、混合物を更
に約室温にまで冷却する。冷却によつて沈殿した固体を
濾取する。この固体はβ−ブロム置換窒素含有異項環化
合物の・・ロゲン化水素酸塩である。この塩を水中に懸
濁し、強塩基でPHを約8〜10に調整して、水蒸気蒸
溜することによりβ−ブロム置換窒素含有異項環化合物
の遊離塩基が得られる。好適な強塩基としては水酸化ナ
トリウム、水酸化カリウムおよび炭酸ナトリウムが挙げ
られる。生成物を冷却した留出物から劇1する。或いは
また、塩基性混合物からクロロホルムまたはエーテルで
抽出することによつても生成物を得ることができる。ク
ロロホルムまたはエーテル抽出物を乾燥し、溶媒を減圧
で留去するとβ−ブロム置換窒素含有異項環化合物を得
ることができる。つぎに実施例を挙げて本発明の具体的
実施態様を説明する。That is, the reaction product mixture is cooled to some extent and a solvent, such as benzene, is added. Other solvents that can be used include hexane, ether, toluene, and xylene. The added solvent dilutes the inert solvent and serves to separate the target substance from the inert solvent. After adding the diluent solvent, the mixture is further cooled to about room temperature. The solids precipitated on cooling are collected by filtration. This solid is a hydrologenide salt of a β-bromine-substituted nitrogen-containing heterocyclic compound. The free base of the β-brome substituted nitrogen-containing heterocyclic compound is obtained by suspending this salt in water, adjusting the pH to about 8 to 10 with a strong base, and steam distilling it. Suitable strong bases include sodium hydroxide, potassium hydroxide and sodium carbonate. The product is extracted from the cooled distillate. Alternatively, the product can also be obtained by extraction with chloroform or ether from the basic mixture. By drying the chloroform or ether extract and distilling off the solvent under reduced pressure, a β-brome substituted nitrogen-containing heterocyclic compound can be obtained. Next, specific embodiments of the present invention will be described with reference to Examples.
本発明の技術的範囲が実施例に記載の範囲に限定される
ものではない。実施例 1
5−ブロムピリミジンの製造:
へら付攪拌器、冷却器、滴下濾斗および温度計を備えた
250meの三頚丸底フラスコに入れたニトロベンゼン
30m1とピリミジン・塩酸塩29.0y(0.25モ
ル)のスラリーを約130℃に加熱し、ブロム44.0
y(0.275モル)を30分を要して滴下濾斗を通し
て滴加する。The technical scope of the present invention is not limited to the scope described in the Examples. Example 1 Preparation of 5-bromopyrimidine: 30 ml of nitrobenzene and 29.0 y of pyrimidine hydrochloride (0.0 ml) and 29.0 y of pyrimidine hydrochloride were placed in a 250 me three-neck round bottom flask equipped with a spatula stirrer, condenser, addition funnel and thermometer. A slurry of 25 mol) of bromine was heated to about 130°C, and
y (0.275 mol) is added dropwise through the addition funnel over a period of 30 minutes.
更に約130℃で2時間加熱攪拌する。反応終了後、反
応混合物を約80℃に冷却し、ベンゼン150m1を添
加する。生ずるスラリーを濾過する。濾取した固体をベ
ンゼン100m1で洗浄し、吸引し乾燥する。乾燥した
黄褐色の固体61.07を水200meに入れる。この
水性混合物を炭酸ナトリウム飽和水溶液でPH8に調整
し、水蒸気蒸留する。留出物を冷却し、白色の固体を濾
取し、一夜空気乾燥する。水性濾液をエチルエーテル1
00meで3回抽出する。エーテル抽出液を合し、これ
を乾燥、濾過し、蒸発して更に生成物を得、これを前に
得た化合物と同じ生成物と合する。生成物の融点約73
〜75℃。収量357(収率88%)。核磁気共鳴スペ
クトルおよび元素分析によつて5−ブロムピリミジンで
あることが確認された。実施例 2〜5
第1表中央欄に記載の溶媒を使用し、実施例1に準する
操作を行つて同表最右欄に示す収率で5−ブロムピリミ
ジンを得る。The mixture is further heated and stirred at about 130°C for 2 hours. After the reaction is complete, the reaction mixture is cooled to about 80° C. and 150 ml of benzene are added. Filter the resulting slurry. The solid collected by filtration is washed with 100 ml of benzene and sucked dry. 61.07 of the dry tan solid is placed in 200 me of water. The aqueous mixture is adjusted to pH 8 with saturated aqueous sodium carbonate solution and steam distilled. Cool the distillate and filter off the white solid and air dry overnight. Transfer the aqueous filtrate to ethyl ether
Extract 3 times with 00me. The ether extracts are combined, which is dried, filtered and evaporated to give further product, which is combined with the same product as the compound obtained previously. Product melting point approximately 73
~75℃. Yield: 357 (88% yield). It was confirmed to be 5-brompyrimidine by nuclear magnetic resonance spectroscopy and elemental analysis. Examples 2 to 5 Using the solvents listed in the middle column of Table 1, the same procedure as in Example 1 was carried out to obtain 5-bromopyrimidine at the yield shown in the rightmost column of the same table.
実施例 6
3−ブロムキノリンの製造:
へら付撹拌器、冷却器、滴下濾斗および温度計を備えた
250m1三顆丸底フラスコに入れたキノリン・塩酸塩
33.3y(0.20モル)とニトロベンゼン50m1
のスラリーを177〜180℃に加熱し、ブロム35.
27(0.22モル)を滴下濾斗を通じて1時間半を要
して滴下する。Example 6 Preparation of 3-bromoquinoline: 33.3y (0.20 mol) of quinoline hydrochloride in a 250 ml three-sided round bottom flask equipped with a paddle stirrer, condenser, dropping funnel and thermometer. Nitrobenzene 50ml
The slurry of 35% bromine was heated to 177-180°C.
27 (0.22 mol) was added dropwise through the dropping funnel over a period of 1.5 hours.
温度を約180℃に維持し、混合物を更に3時間20分
攪拌すると塩化水素の発生が止まる。加熱を止め、反応
混合物を室温に冷却し、ベンゼン200meを加える。
混合物を濾過し、固体を濾取しベンゼン100w11で
洗浄し、濾過器上で吸引し乾燥する。かくして粗生成物
48.7yが得られる。この粗生成物に水200m1を
加え、これに炭酸ナトリウム飽和水溶液を加えて塩基性
にする。塩基性の混合物をエーテル200m1で4回抽
出する。エーテル抽出物を合し、乾燥し、溶媒を減圧で
除去して淡黄色の油状物35.1yを得る。この油状物
を冷蔵庫中に置いて固化させる。この固体の融点は約1
2〜13℃であり、3−ブロムキノリンであることが確
認された。収率84.5%、気相クロマトグラフイ一に
よる純度97%o実施例 7
4−ブロムイソキノリンの製造:
上記実施例1と同様の方法に従つて次のように実施した
。The temperature was maintained at about 180° C. and the mixture was stirred for an additional 3 hours and 20 minutes until hydrogen chloride evolution ceased. Stop heating, cool the reaction mixture to room temperature, and add 200 me of benzene.
The mixture is filtered and the solid is filtered off, washed with 100w11 of benzene and sucked dry on the filter. 48.7y of crude product are thus obtained. 200 ml of water are added to the crude product, which is made basic by adding saturated aqueous sodium carbonate solution. The basic mixture is extracted four times with 200 ml of ether. The ether extracts are combined, dried and the solvent removed under reduced pressure to give a pale yellow oil, 35.1y. Place this oil in the refrigerator to solidify. The melting point of this solid is approximately 1
The temperature was 2 to 13°C, and it was confirmed that it was 3-bromoquinoline. Yield 84.5%, purity 97% by gas phase chromatography Example 7 Production of 4-bromiisoquinoline: The following procedure was carried out in the same manner as in Example 1 above.
還流冷却器、滴下濾斗、温度計および攪拌器を備えたフ
ラスコ中に、イソキノリン・塩酸塩33,3f7(0.
20モル)をニトロベンゼン50m1と共に入れ、この
混合物を攪拌し、約180℃に加熱し、透明な黄色の溶
液を得る。この溶液に滴下濾斗を通じて1時間13分を
要してブロム35.2y(0.22モル)を滴加する。
塩化水素の発生はブロムの添加の最初から最後まで円滑
であつた。ブロムを全部添加し終つた後、反応混合物は
単一層であり、こはく赤色である。ブロムを添加した後
、これを更に約180℃に加熱し、撹拌を続ける。1時
間後にフラスコ中の冷却器の近くに固体結晶が析出し始
める。In a flask equipped with a reflux condenser, dropping funnel, thermometer and stirrer, add isoquinoline hydrochloride 33,3f7 (0.
20 mol) with 50 ml of nitrobenzene and the mixture is stirred and heated to about 180° C. to obtain a clear yellow solution. Bromine 35.2y (0.22 mol) is added dropwise to this solution through an addition funnel over a period of 1 hour and 13 minutes.
Hydrogen chloride evolution was smooth throughout the bromine addition. After all the bromine has been added, the reaction mixture is a single layer and amber red in color. After adding the bromine, it is further heated to about 180° C. and stirring is continued. After 1 hour solid crystals begin to precipitate in the flask near the condenser.
3時間15分加熱攪拌した後、結晶の極めて希薄なスラ
リーが生成し始め、塩化水素の発生は非常に緩慢になる
。After heating and stirring for 3 hours and 15 minutes, a very dilute slurry of crystals begins to form and hydrogen chloride evolution becomes very slow.
4時間45分加熱攪拌を続けると塩化水素の発生は事実
上停止する。When heating and stirring were continued for 4 hours and 45 minutes, the generation of hydrogen chloride virtually stopped.
熱源を除去し、殆んど透明なこはく色の溶液をゆつくり
と放冷する。Remove the heat source and allow the almost clear amber solution to cool slowly.
約150℃で急激に結晶化する。約90℃でベンゼン2
00meをこのスラリーに加え、混合物を約15分間攪
拌する。続いて混合物を約20℃に冷却し、濾過すると
細かい綿のような針状結晶が得られる。これをベンゼン
100m1で洗浄し、ついでベンゼン200meで再び
スラリーにし、濾過し、乾燥する。得られた生成物46
.6Vを水200m1に入れ、炭酸水素ナトリウム飽和
溶液を加えて塩基性にする。この塩基性混合物をエーテ
ル200m1で4回抽出する。エーテル抽出物を合し、
無水硫酸マグネシウムで乾燥する。乾燥剤を濾過し、エ
ーテル層を蒸発して淡黄色の油状物33.6f7を得る
。これを放置しておくと結晶化する。蒸気相クロマトグ
ラフイ一により、この粗物質は4−ブロムイソキノリン
を93.5%含有することが示された。4−ブロムイソ
キノリンの全収率は約80.5%であつた。It crystallizes rapidly at about 150°C. Benzene 2 at about 90℃
Add 00me to this slurry and stir the mixture for about 15 minutes. The mixture is then cooled to about 20° C. and filtered to obtain fine cotton-like needles. This is washed with 100 ml of benzene, then reslurried with 200 ml of benzene, filtered, and dried. The product obtained 46
.. 6V in 200 ml of water and made basic by adding saturated sodium bicarbonate solution. This basic mixture is extracted four times with 200 ml of ether. Combine the ether extracts,
Dry with anhydrous magnesium sulfate. Filter the desiccant and evaporate the ether layer to obtain a pale yellow oil, 33.6f7. If left alone, it will crystallize. Vapor phase chromatography showed that the crude material contained 93.5% 4-bromoisoquinoline. The overall yield of 4-bromoisoquinoline was about 80.5%.
粗製物質を石油エーテルから再結晶して融点約41〜4
2℃の生成物を得る。実施例 8
5−ブロム−4−フエニルピリミジンの製造:上記実施
例の方法に従い、攪拌器、温度計、冷却器および滴下濾
斗を備えた三頚フラスコに、4ーフエニルピリミジン・
塩酸塩11.07(0.0572モル)とニトロベンゼ
ン30m1の混合物を入れて攪拌し、油浴上、約15『
Cで加熱し、ブロム9.2y(0.0575モル)を3
5分を要して滴下する。The crude material was recrystallized from petroleum ether to a melting point of about 41-4
Obtain the product at 2°C. Example 8 Preparation of 5-bromo-4-phenylpyrimidine: According to the method of the above example, 4-phenylpyrimidine.
A mixture of 11.07 (0.0572 mol) of hydrochloride and 30 ml of nitrobenzene was added, stirred, and heated on an oil bath for about 15 minutes.
Heating at C, bromine 9.2y (0.0575 mol) was
It takes 5 minutes to drip.
直ちに塩化水素の発生が始まる。反応混合物を、ブロム
の添加後約5.5時間150℃で加熱、撹拌する。次い
で、反応混合物を約105゜Cに冷却し、ベンゼン10
0m′を添加する。Hydrogen chloride generation begins immediately. The reaction mixture is heated and stirred at 150° C. for approximately 5.5 hours after addition of the bromine. The reaction mixture was then cooled to about 105°C and diluted with benzene 10
Add 0m'.
更に冷却を続け、約47℃で褐色の固体が分離し、スラ
リーを形成する。混合物を約20分間撹拌しながら室温
に冷やす。析出した固体物質を劇uし、ニトロベンゼン
とベンゼンの混合物である濾液は更に処理するために保
存する。ブフナ一濾斗上のゴム状物質を水に懸濁し、こ
の混合物を50%水酸化ナトリウム水溶液4.27を加
えて塩基性にする。塩基性水性混合物をクロロホルムで
抽出する。クロロホルム抽出液を合し、無水硫酸マグネ
シウムで乾燥し、蒸発してゴム状固形物6.1yを得る
。蒸気相クロマトグラフイ一分析によつて、ゴム状固形
物は4一フエニルピリミジン71%および目的物質であ
る4−フエニル一5−ブロムピリミジン29%から成る
ことが示された。前記の反応混合物の最初の処理で得ら
れたニトロベンゼンとベンゼンの混液から成る濾液から
更に固形物5.97を回収した。この固形物を蒸気相ク
ロマトグラフイ一で定量して、原料の4−フエニルピリ
ミジン39%と生成物5−ブロム−4−フエニルピリミ
ジン61%を含むことが確認された。実施例 9
3・8−ジブロム−1・6−ナフテリジンの製造:実施
例1に記載の方法に従い、1・6−ナフテリジン・塩酸
塩9.8f1(0.0589モル)とニトロベンゼン2
0m1の混合物を180℃に加熱し、約50分を要して
ブロム10.367(10%モル過剰量)を滴加する。Further cooling is continued and at about 47° C. a brown solid separates to form a slurry. Cool the mixture to room temperature while stirring for about 20 minutes. The precipitated solid material is removed and the filtrate, a mixture of nitrobenzene and benzene, is saved for further processing. The gummy material on the Buchna funnel is suspended in water and the mixture is made basic by adding 4.27 g of 50% aqueous sodium hydroxide solution. The basic aqueous mixture is extracted with chloroform. The chloroform extracts are combined, dried over anhydrous magnesium sulfate and evaporated to give a gummy solid 6.1y. Vapor phase chromatography analysis showed that the gummy solid consisted of 71% 4-phenylpyrimidine and 29% of the desired product, 4-phenyl-5-bromopyrimidine. An additional 5.97 ml of solid material was recovered from the filtrate consisting of a mixture of nitrobenzene and benzene from the first treatment of the reaction mixture. This solid was quantified by vapor phase chromatography and confirmed to contain 39% of the raw material 4-phenylpyrimidine and 61% of the product 5-bromo-4-phenylpyrimidine. Example 9 Preparation of 3,8-dibromo-1,6-naphteridine: According to the method described in Example 1, 1,6-naphteridine hydrochloride 9.8f1 (0.0589 mol) and nitrobenzene 2
0 ml of the mixture is heated to 180° C. and bromine 10.367 (10% molar excess) is added dropwise over a period of approximately 50 minutes.
プロム添加終了後、反応混合物を約178〜180℃で
更に3時間半加熱、攪拌する。反応混合物を約90℃に
冷却し、これにベンゼン100m1を添加する。生成し
た黄褐色の固体を濾取し、エーテルおよびベンゼンで洗
浄する。固体約157が得られる。この黄褐色の固体を
水約100m1に入れる。固形炭酸ナトリウムを用いて
混合物のPHを約8に調整し、この塩基性混合物をクロ
ロホルム200m1で4回抽出する。クロロホルム抽出
物を合し、乾燥し、クロロホルムを蒸発乾固して黄褐色
固体8.7yを得る。蒸気相クロマトグラフイ一により
出発物質である1・6−ナフチリジンの遊離塩基と目的
物質の2つの主成分から成ることが示されている。この
粗生成物を四塩化炭素中5%酢酸エチル溶液を用いて、
グレード3のアルミナ上、クロマトグラフイ一処理する
。これにより4.47の目的物質が得られた。これは核
磁気共鳴スペクトルで3・8−ジブロム−1・6−ナフ
チリジンであることが確認された。この物質を市販の無
水エタノールから再結晶して融点約186〜188゜C
の針状結晶3.8yが得られる。上記実施例で得られた
種々のブロム置換窒素含有異項環化合物は興昧ある医薬
品、動物用医薬および農薬製造用中間体として有用であ
る。After the prom addition is complete, the reaction mixture is heated and stirred for an additional 3.5 hours at about 178-180°C. The reaction mixture is cooled to about 90° C. and 100 ml of benzene are added thereto. The tan solid formed is filtered off and washed with ether and benzene. Approximately 157 ml of solid is obtained. This tan solid is placed in about 100 ml of water. The pH of the mixture is adjusted to about 8 using solid sodium carbonate and the basic mixture is extracted 4 times with 200 ml of chloroform. The chloroform extracts are combined, dried and the chloroform is evaporated to dryness to yield 8.7y of a tan solid. Vapor phase chromatography shows that it consists of two main components: the free base of 1,6-naphthyridine, which is the starting material, and the target material. This crude product was purified using a 5% ethyl acetate solution in carbon tetrachloride.
Chromatographed on grade 3 alumina. This yielded 4.47 of the target substance. This was confirmed to be 3,8-dibromo-1,6-naphthyridine by nuclear magnetic resonance spectroscopy. This material was recrystallized from commercially available absolute ethanol to a melting point of approximately 186-188°C.
3.8y of needle-like crystals are obtained. The various bromine-substituted nitrogen-containing heterocyclic compounds obtained in the above examples are useful as intermediates for producing interesting pharmaceuticals, veterinary medicines, and agricultural chemicals.
例えば5−プロムピミリジンは、多くの植物病源性菌類
抑制のための殺菌剤として、或いは植物生長調整剤とし
て有用な或種の置換5−ピリミジンメタノールの合成に
利用される。これに関し、前記文献に引用されたペルキ
ー特許第714003号は、ドライアイス−アセトンの
冷浴の低温でn−ブチルリチウムの存在下、5−ブロム
ピリミジンにケトンを反応させることによつて、5一置
換ピリミジンメタノールを得る合成法を開示している。
4−ブロムイソキノリンは4−スルフアニルアミドイソ
キノリンの製造に使用することができる。For example, 5-prompimyridine is utilized in the synthesis of certain substituted 5-pyrimidine methanols that are useful as fungicides for the control of many phytopathogenic fungi or as plant growth regulators. In this regard, Pelkey Patent No. 714003, cited in the above-mentioned document, discloses that 5-bromopyrimidine is prepared by reacting a ketone with 5-bromopyrimidine in the presence of n-butyllithium at the low temperature of a dry ice-acetone cold bath. A synthetic method for obtaining substituted pyrimidine methanol is disclosed.
4-bromoisoquinoline can be used to make 4-sulfanylamide isoquinoline.
この物質はグレーグ(Crajg)およびキヤス(Ca
ss)によつて報告〔ザ・ジヤーナル・オブ・ジ・アメ
リカン・ケミカル・ソサエテイ第64巻783頁(19
42年)参照〕されているように、抗菌剤として有用で
ある。3−ブロムキノリンは、セイバート(Sejbe
rt)等によつて報告〔ザ・ジャーナル・オブ・ジ・ア
メリカン・ケミカル・ソサエテイ第68巻2722頁に
おける2721(1946年)参照〕されているように
α−(2−ピペリジル)−3−キノリンメタノールの製
造に使用することができる。This material is known by Craig and Ca
ss) [The Journal of the American Chemical Society, Vol. 64, p. 783 (19
42), it is useful as an antibacterial agent. 3-Bromoquinoline is available from Sejbe
α-(2-piperidyl)-3-quinoline as reported by [The Journal of the American Chemical Society Vol. 68, p. 2722, 2721 (1946)]. It can be used in the production of methanol.
このキノリンメタノール化合物は、あひるにおけるロフ
ラエ・マラリヤ(LOphuraemalaria)に
対して活性を有することが報告されている〔ワィズログ
ル(WiselOgle)著:ア・サベイ・オブ・アン
チマラリアル・ドラツグズ、1941〜1945年度(
発行者:米国ミシガン州アン・アルバ一在ジエ・ダブル
ユ・エドワーズ(1946年刊))第1巻149頁表1
7参照〕。5−ブロム−4−フエニルピリミジンはトリ
コフイトン.、メンタグロフイテス(TrichOpl
lytOnmentagrOphytes)およびボト
リテイス・シネレア(BOtrytiscinerea
)に対して抗菌活性を有している。This quinoline methanol compound has been reported to have activity against Lophurae malaria in ducks (WiselOgle, A Survey of Antimalarial Drugs, 1941-1945).
Publisher: Jie Doubleu Edwards, Ann Alba, Michigan, USA (published in 1946) Volume 1, page 149 Table 1
7]. 5-bromo-4-phenylpyrimidine is trichophyton. , Mentagrophytes (TrichOpl)
lytOnmentagrOphytes) and Botrytiscinerea
) has antibacterial activity against
Claims (1)
ルピリミジンおよび1・6−ナフチリジンからなる群か
ら選ばれる窒奏含有異項環化合物の塩酸塩または臭化水
素酸塩を、ブロム化反応条件下においてブロムの作用に
対して実質的に不活性な溶媒と混合し、この混合物を1
25℃〜200℃の温度に加熱保持し、この加熱混合物
にブロムを徐々に添加し、添加終了後この反応混合物を
125℃〜200℃に更に2〜6時間保持することから
なる5−ブロモピリミジン、3−ブロモキノリン、4−
ブロモイソキノリン、5−ブロモ−4−フェニルピリミ
ジンおよび3・8−ジブロモ−1・6−ナフチリジンか
らなる群から選ばれるβ−ブロモ窒素含有異項環化合物
の改良製造法であつて、該溶媒がニトロベンゼン、ベン
ゾニトリル、o−ニトロトルエン、o−ジクロロベンゼ
ンおよびo−ニトロアニソールからなる群から選ばれる
ものであることを特徴とする製造法。1. Hydrochloride or hydrobromide of a nitride-containing heterocyclic compound selected from the group consisting of pyrimidine, quinoline, isoquinoline, 4-phenylpyrimidine and 1,6-naphthyridine is treated under bromination reaction conditions with the action of bromine. and a solvent that is substantially inert to
5-bromopyrimidine consisting of heating and holding at a temperature of 25°C to 200°C, gradually adding bromine to this heated mixture, and after the addition is complete, holding the reaction mixture at 125°C to 200°C for a further 2 to 6 hours. , 3-bromoquinoline, 4-
An improved method for producing a β-bromo nitrogen-containing heterocyclic compound selected from the group consisting of bromoisoquinoline, 5-bromo-4-phenylpyrimidine and 3,8-dibromo-1,6-naphthyridine, the solvent being nitrobenzene. , benzonitrile, o-nitrotoluene, o-dichlorobenzene, and o-nitroanisole.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30838972A | 1972-11-21 | 1972-11-21 | |
US308389 | 1972-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS4981375A JPS4981375A (en) | 1974-08-06 |
JPS596854B2 true JPS596854B2 (en) | 1984-02-15 |
Family
ID=23193800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP48131177A Expired JPS596854B2 (en) | 1972-11-21 | 1973-11-21 | Bromination method for heterocycle-containing heterocyclic compounds |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS596854B2 (en) |
BE (1) | BE807525A (en) |
CH (1) | CH584205A5 (en) |
DE (1) | DE2356358C2 (en) |
FR (1) | FR2207100B1 (en) |
GB (1) | GB1439682A (en) |
IL (1) | IL43505A (en) |
IT (1) | IT1001824B (en) |
NL (1) | NL184058C (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2221808A1 (en) * | 1972-05-04 | 1972-11-16 | Sandoz Ag | Antihypertensive 3-hydrazino-tetrahydro-pyridopyridazines - - from corresponding 3-halo compounds and excess hydrazines |
-
1973
- 1973-10-29 IL IL43505A patent/IL43505A/en unknown
- 1973-10-30 GB GB5046973A patent/GB1439682A/en not_active Expired
- 1973-11-06 CH CH1558773A patent/CH584205A5/xx not_active IP Right Cessation
- 1973-11-12 DE DE2356358A patent/DE2356358C2/en not_active Expired
- 1973-11-16 NL NLAANVRAGE7315788,A patent/NL184058C/en not_active IP Right Cessation
- 1973-11-16 IT IT31462/73A patent/IT1001824B/en active
- 1973-11-20 BE BE1005515A patent/BE807525A/en not_active IP Right Cessation
- 1973-11-21 FR FR7341410A patent/FR2207100B1/fr not_active Expired
- 1973-11-21 JP JP48131177A patent/JPS596854B2/en not_active Expired
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2221808A1 (en) * | 1972-05-04 | 1972-11-16 | Sandoz Ag | Antihypertensive 3-hydrazino-tetrahydro-pyridopyridazines - - from corresponding 3-halo compounds and excess hydrazines |
Also Published As
Publication number | Publication date |
---|---|
NL184058B (en) | 1988-11-01 |
FR2207100A1 (en) | 1974-06-14 |
BE807525A (en) | 1974-05-20 |
JPS4981375A (en) | 1974-08-06 |
NL184058C (en) | 1989-04-03 |
IL43505A0 (en) | 1974-01-14 |
CH584205A5 (en) | 1977-01-31 |
IL43505A (en) | 1977-04-29 |
IT1001824B (en) | 1976-04-30 |
DE2356358C2 (en) | 1984-12-06 |
DE2356358A1 (en) | 1974-05-30 |
FR2207100B1 (en) | 1981-06-19 |
NL7315788A (en) | 1974-05-24 |
GB1439682A (en) | 1976-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS626703B2 (en) | ||
EP2907812B1 (en) | Process for the preparation of an amorphous form of dexlansoprazole | |
LU88049A1 (en) | BIS (ACYLOXY-O) BORATE (ACID-O3, O4-6,7-SUBSTITUE-8-ALCOXY-L-CYCLOPROPYL-1,4-DIHYDRO-4-OXO-3-QUINOLEINECARBOXYLIC AND SALT THEREOF , AS WELL AS THEIR PREPARATION PROCESS | |
JP6592085B2 (en) | Preparation method of revaprazan hydrochloride | |
EP4073056B1 (en) | Process for the preparation of lasmiditan and of a synthesis intermediate | |
US4066665A (en) | 2-Alkylamino-α-phenyl-1-cyclohexene-1-methyleneimine, its salts and preparation | |
JP2004520446A (en) | Crystallization method of losartan potassium | |
DE60021286T2 (en) | PROCESS FOR PREPARING PYRAZOLO [1,5-B] PYRIDAZINE DERIVATIVES | |
EP0412899B1 (en) | Oxazolo pyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
US3201406A (en) | Pyridylcoumarins | |
JPS596854B2 (en) | Bromination method for heterocycle-containing heterocyclic compounds | |
JPH0136462B2 (en) | ||
JPS6272662A (en) | 4-alkoxy-3-pyrroline-2-one-1-yl-acetic acid alkyl ester and manufacture | |
JP2012506367A (en) | Crystalline Montelukast salt | |
US3956301A (en) | Process for bromination of pyrimidine | |
JPH029854A (en) | Production of 3-amino-acrylonitrile | |
JPH02149550A (en) | N-(2-carboxy-3',4'-dimethoxy-cynnamoyl)-anthranilic acid, and production thereof | |
FR2487346A1 (en) | 4-OXIMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THERAPEUTIC APPLICATION THEREOF | |
AU2004232454B2 (en) | Method for the production of nicotinaldehydes | |
JP2000229944A (en) | Production of 6-hydroxy-2-oxo-1,2,3,4-terrahydroquinoline | |
JPH0558985A (en) | Production of cyanoguanidine derivative | |
CN106432095B (en) | The preparation of -3 (2H) -one of pimobendan key intermediate 6- (3,4- diamino-phenyl) -5- methyl -4,5- dihydrogen dazin | |
CN109970733B (en) | Simple preparation method of vemurafenib and analogue thereof | |
JPS61178970A (en) | Manufacture of novel 2-substituted 1,4-benzodiazepine | |
Bogert et al. | RESEARCHES ON QUINAZOLINES (TWENTY-NINTH PAPER). A FURTHER STUDY OF THE STILBAZOLES, HYDRAZONES AND SCHIFF BASES OF THE 4-QUINAZOLONE GROUP. |